📊 Evidence-Based Reference

Indigo Aspiration System - Lightning Flash

Penumbra, Inc.

Product: Indigo System — all models and sizes

Contact a rep Compare similar devices

Summary: The Indigo Aspiration System by Penumbra is a mechanical thrombectomy device primarily used for venous thrombus removal. Key evidence highlights its application in complex thrombotic conditions, including pediatric cases.

FDA Clearance Information

Pathway ? 510(k)
Number ? K222358 ↗
Decision Date ? December 20, 2022
Product Code ? QEW Peripheral Mechanical Thrombectomy With Aspiration
Device Class ? Class 2
Evidence ? 40 studies

The Indigo Aspiration System was cleared by the FDA through the 510(k) pathway on December 20, 2022. It is manufactured by Penumbra and classified as a Class 2 medical device.

What It Is

The Indigo Aspiration System is a mechanical thrombectomy device designed for the removal of thrombi from the venous system. It utilizes aspiration technology to extract clots, providing a minimally invasive option for thrombus management.

FDA-Cleared Indications

  • Removal of thrombus from the peripheral vasculature using aspiration thrombectomy.
  • Treatment of thromboembolism and thrombosis in vessels that can be reached with the compatible Indigo catheter system.
  • Use in adults and pediatric patients when the selected catheter size and system components are appropriate for the patient and vessel.

Clinical Applications

  • Aspiration thrombectomy for selected lower-extremity deep vein thrombosis.
  • Aspiration thrombectomy for selected pulmonary embolism cases.
  • Thrombectomy of selected thrombosed dialysis grafts or fistulas.
  • Removal of thrombus from other labeled peripheral vascular locations using the appropriate Indigo catheter and aspiration system.

Reported off-label uses

  • Aspiration thrombectomy in selected arterial thrombotic or embolic occlusions when the use is outside the specific cleared indication for the chosen device configuration.
  • Treatment of unusual or anatomically complex venous thrombi not specifically described in the device labeling.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes 7 studies, comprising case reports and retrospective analyses, published between 2024 and 2025. These studies explore the device's application in various thrombotic conditions.

Reported Outcomes

Published studies report successful thrombus removal in complex cases, including pediatric patients and those with high-risk pulmonary embolism. The device has shown efficacy in reducing thrombus burden and improving clinical outcomes.

Safety Profile

Reported complications include minor bleeding and access site hematomas. No major adverse events directly attributed to the device were noted in the reviewed studies.

Evidence Limitations

The evidence is limited by the small number of studies and the predominance of case reports. Further research is needed to establish long-term outcomes and comparative efficacy against other thrombectomy devices.

Practical Considerations

  • The system includes different catheter sizes and compatible components; selection depends on vessel diameter, clot burden, access route, and the specific product configuration.
  • The procedure is performed under fluoroscopic imaging through vascular access, commonly from the femoral or jugular vein and, for selected arterial procedures, an arterial access site.
  • The system is intended for use by trained clinicians familiar with endovascular thrombectomy, aspiration pumps, and management of bleeding, embolization, and vascular injury.
  • MRI safety depends on the specific catheter, tubing, and other components. The device should not be assumed to be MRI safe or MRI conditional unless the applicable labeling confirms it; retained or implanted components require separate evaluation.
  • Contraindications and warnings include unsuitable vessel anatomy, inability to safely obtain vascular access, active bleeding or severe bleeding risk, and risks related to anticoagulation, contrast, sedation, vascular injury, distal embolization, and incomplete clot removal.

Procedures that use this device

Linked Studies (20)

PubMed • 2025

Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial.

Circulation

RCT|prospective View Source →
PubMed • 2025

A New Technique for Mechanical Thrombectomy in Patients With Acute Pulmonary Embolism: A Case Series.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Case Series View Source →
PubMed • 2025

Rescue catheter directed treatment for floating right atrial thrombi and deep vein thrombosis in patient with high-risk acute pulmonary embolism: a case report of multidisciplinary approach.

European heart journal. Case reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Percutaneous vacuum-assisted tumor thrombectomy using angiovac and penumbra lightning 12 aspiration systems.

Radiology case reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Safety and efficacy of mechanical aspiration thrombectomy for patients with acute lower extremity ischemia.

Journal of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Neuro-tracking catheter technology for coronary thrombus extraction: Indigo CAT RX Continuous Aspiration System - first use in Poland.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

View Source →
PubMed • 2024

[Interventional therapy of pulmonary embolism - update].

Deutsche medizinische Wochenschrift (1946)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Super-Elderly Case of Acute Lower Limb Ischemia Treated with Indigo Aspiration System in Japan.

Annals of vascular diseases

Case Series View Source →
PubMed • 2024

Procedure-Related Mortality in Aspiration Thrombectomy for Pulmonary Embolism: A MAUDE Database Analysis of the Inari FlowTriever and Penumbra Indigo Systems.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Endovascular thrombectomy for cerebral venous sinus thrombosis using the Penumbra Indigo® Aspiration System.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Other View Source →
PubMed • 2024

Anesthetic Management for Aspiration Thrombectomy Using the Penumbra Indigo System in Pediatric Patients with Congenital Heart Disease.

Journal of cardiothoracic and vascular anesthesia

Other View Source →
PubMed • 2024

Penumbra Indigo® system to safely remove intracardiac thrombus in a 7-month-old infant with severe immunodeficiency disorder.

Cardiology in the young

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Case Report: Catheter-based mechanical thrombectomy using the Indigo aspiration system in a case of systemic-to-pulmonary shunt thrombosis.

Frontiers in pediatrics

Case Report View Source →
PubMed • 2023

Mechanical Venous Thrombectomy Using Indigo Aspiration System: A Case Report.

Cureus

View Source →
PubMed • 2023

Indigo® Aspiration System for thrombectomy in pulmonary embolism.

Future cardiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Penumbra Indigo Percutaneous Aspiration Thrombectomy System in the treatment of Aortic Endograft Iliac Limb Occlusion: Results from an Italian Multicentre Registry.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Aspiration Thrombectomy with the Indigo System for Acute Lower Limb Ischemia: Preliminary experience and analysis of parameters affecting the outcome.

Annals of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Complications and Failure Modes of the Penumbra Indigo CAT RX Aspiration System in Percutaneous Coronary Intervention: Insights From the MAUDE Database.

Cardiovascular revascularization medicine : including molecular interventions

View Source →
PubMed • 2022

Technical success and short-term results from mechanical thrombectomy for lower extremity iliofemoral deep vein thrombosis using a computer aided mechanical aspiration thrombectomy device.

Journal of vascular surgery. Venous and lymphatic disorders

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Indigo Aspiration System?

The Indigo Aspiration System is indicated for mechanical thrombectomy in venous thrombotic conditions, such as deep vein thrombosis and pulmonary embolism.

What outcomes have been reported in clinical studies?

Clinical studies have reported successful thrombus removal and improved patient outcomes, particularly in complex and high-risk thrombotic cases.

What complications have been reported?

Safety data from evidence indicates minor bleeding and access site hematomas as reported complications.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you